Cargando…
CYP21A2 mutations in pediatric patients with congenital adrenal hyperplasia in Costa Rica
Steroid 21-hydroxylase deficiency accounts for 95% of congenital adrenal hyperplasia (CAH) cases. Newborn screening has allowed for early detection of the disease, and currently, molecular analysis can identify the genotypes of these patients. Phenotype-genotype correlation has been well described i...
Autores principales: | Umaña-Calderón, Andrés, Acuña-Navas, María José, Alvarado, Danny, Jiménez, Mildred, Cavallo-Aita, Fred |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875833/ https://www.ncbi.nlm.nih.gov/pubmed/33604243 http://dx.doi.org/10.1016/j.ymgmr.2021.100728 |
Ejemplares similares
-
SAT-LB049 Identification of a Rare Mutation in Congenital Adrenal Hyperplasia Patients in Costa Rica
por: Umaña Calderón, Andrés, et al.
Publicado: (2019) -
Novel variants of CYP21A2 in Vietnamese patients with congenital adrenal hyperplasia
por: Chi, Dung V., et al.
Publicado: (2019) -
Variant predictions in congenital adrenal hyperplasia caused by mutations in CYP21A2
por: Prado, Mayara J., et al.
Publicado: (2022) -
Wilson disease in Costa Rica: Pediatric phenotype and genotype characterization
por: Penon‐Portmann, Monica, et al.
Publicado: (2020) -
Molecular genetic analysis of CYP21A2 gene in patients with congenital adrenal hyperplasia
por: Marumudi, Eunice, et al.
Publicado: (2012)